Quarterly Returns (%)BioCryst Pharmaceuticals Inc
| Years | Q1 | Q2 | Q3 | Q4 | Annual |
|---|---|---|---|---|---|
| 1994 | 0 | -9.1 | 10 | -15.8 | 0 |
| 1995 | 35 | 54.1 | 6.4 | -2.6 | 99.8 |
| 1996 | 1.4 | 77.1 | -20.3 | 28.5 | 77.1 |
| 1997 | -27.5 | 15.7 | -41.8 | -12.5 | -57.3 |
| 1998 | 7.1 | 4.1 | -10.4 | 0 | 0 |
| 1999 | -8.9 | 37.2 | 177.1 | 21.7 | 321.4 |
| 2000 | -7.4 | 5.1 | -27.5 | -66.8 | -77.5 |
| 2001 | -6.6 | 4.2 | -42.6 | 13.1 | -40.3 |
| 2002 | 15.4 | -80.5 | 27.1 | -21.3 | -75.8 |
| 2003 | 58.3 | 139.5 | 83 | 2.9 | 613.5 |
| 2004 | 21.9 | -17.4 | -26.1 | 13.3 | -15.6 |
| 2005 | -20.2 | 10.2 | 92.5 | 71.3 | 189.8 |
| 2006 | 7.8 | -20.7 | -13 | -0.2 | -31 |
| 2007 | -27.6 | -5.7 | -9.6 | -16.7 | -46.5 |
| 2008 | -25.4 | -39.3 | 12.5 | -56.5 | -77.8 |
| 2009 | 59.9 | 84 | 104.5 | -21.6 | 371.5 |
| 2010 | 1.7 | -10.1 | -16.4 | 4.7 | -20 |
| 2011 | -26.7 | 0.8 | -27.8 | -10.5 | -52.2 |
| 2012 | 95.6 | -20.1 | 4.4 | -67.1 | -42.5 |
| 2013 | -16.2 | 12.3 | 352.2 | 4.4 | 435.2 |
| 2014 | 39.2 | 20.5 | -23.3 | 24.3 | 60 |
| 2015 | -25.7 | 65.3 | -23.6 | -9.5 | -15.1 |
| 2016 | -72.6 | 0.4 | 55.3 | 43.5 | -38.7 |
| 2017 | 32.7 | -33.8 | -5.8 | -7.9 | -22.4 |
| 2018 | -2.9 | 24.3 | 34.6 | 10.7 | 64.4 |
| 2019 | 0.9 | -56.2 | -20.1 | 8.1 | -59.3 |
| 2020 | -5 | 4 | 8 | 116.6 | 126.8 |
| 2021 | 36.5 | 55.5 | -7.2 | -4.5 | 88.1 |
| 2022 | 16 | -34.9 | 19.1 | -8.9 | -18.1 |
| 2023 | -27.4 | -15.6 | 0.6 | -11.5 | -47.8 |
| 2024 | -15 | 21 | 19.3 | -8.3 | 25.5 |
| 2025 | 2.5 | 0 | 0 | 32.6 |